Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Clin Infect Dis. 2011 Jul 1;53(1):e1-7. doi: 10.1093/cid/cir268.
Nontypeable (unencapsulated) strains of Haemophilus influenzae (ntHi) are usually involved in respiratory tract infections and otitis media but may also cause invasive disease. The epidemiology, the course of disease, and the outcome of ntHi invasive disease are not well established. For prevention, risk groups that might benefit from vaccination have to be defined.
All patients with ntHi invasive disease confirmed by culture of samples collected by the Netherlands Reference Laboratory for Bacterial Meningitis from 41 sentinel hospitals and representative of ∼45% of all Dutch hospitalized ntHi case patients over the period from 2001 through 2008 were included in the study. Data on clinical presentation, course of disease, and outcome as well as patient characteristics and comorbidity were retrospectively retrieved from hospital records.
Clinical presentations of 396 cases included mainly invasive pneumonia (190 cases [48%]) and bacteremia without a clinical focus (75 cases [19%]). Comorbidities were present in 327 [83%] and immunodeficiency in 173 [44%] of all cases. The overall case fatality rate within the first month after diagnosis was 12% and the lowest (2%) was among patients aged 5-54 years. The highest extrapolated age-specific incidence rates occurred within the first 6 weeks of life (19.0 cases per 100,000 persons), concerning mostly prematurely born infants with bacteremia within 24 h after birth, and in the first year of life (5.6 cases per 100,000 persons). The highest rate in adults was among elderly patients aged >65 years (2.2 cases per 100,000 persons).
This study provides a detailed overview of invasive ntHi disease cases in the Netherlands. Risk groups are prematurely born infants, elderly patients aged >65 years, and immunocompromised patients.
无荚膜(未包裹)流感嗜血杆菌(ntHi)通常与呼吸道感染和中耳炎有关,但也可能引起侵袭性疾病。ntHi 侵袭性疾病的流行病学、病程和结局尚不清楚。为了预防,必须确定可能受益于疫苗接种的风险群体。
所有经荷兰细菌脑膜炎参考实验室从 41 家监测医院采集样本培养确认的 ntHi 侵袭性疾病患者,以及代表 2001 年至 2008 年间荷兰所有住院 ntHi 病例患者的约 45%,都被纳入了本研究。从医院记录中回顾性地检索了临床表现、疾病过程和结局以及患者特征和合并症的数据。
396 例临床病例的表现主要包括侵袭性肺炎(190 例[48%])和无临床焦点的菌血症(75 例[19%])。所有病例中有 327 例(83%)存在合并症,173 例(44%)存在免疫缺陷。诊断后第一个月的总病死率为 12%,最低(2%)见于 5-54 岁的患者。第一个 6 周内的年龄特异性发病率最高(每 10 万人 19.0 例),主要涉及出生后 24 小时内出现菌血症的早产儿,以及 1 岁以下儿童。成年人中发病率最高的是年龄>65 岁的老年患者(每 10 万人 2.2 例)。
本研究详细介绍了荷兰 ntHi 侵袭性疾病病例。风险群体是早产儿、年龄>65 岁的老年患者和免疫功能低下的患者。